Discusses MissionEB Phase III Trial and CORDStrom as a Disease-Modifying Therapy for RDEB February 26, 2026 1:00 PM ...

Good morning, and welcome to the Rallybio Corporation conference call to discuss the merger of Rallybio and Candid Therapeutics. It is now my pleasure to turn the call over to Dr. Stephen Uden, ...

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein ...

AI-generated content errors aren't disappearing. Courts have sanctioned attorneys for filing briefs with fabricated case citations produced by generative AI. Healthcare professionals risk patient harm ...

Rovier Carrington thought his cases against MTV and Paramount executives should have been the biggest of the #MeToo era. Instead, they raised unsettling questions about victimhood ...

With the rampant spread of AI (and the hype), tech stocks were bound to crash at some point – a jolt to make the industry rethink and reshape itself. Recent ...

Ginkgo Bioworks Holdings, Inc. today announced its results for the fourth quarter and full year ended December 31, 2025. The update, including a webcast slide presentation with additional details on ...

AbCellera Biologics Inc. (NASDAQ: ABCL) Q4 2025 Earnings Call Transcript February 24, 2026 AbCellera Biologics Inc. beats ...

We’ve spoken several times before, but can you just give our readers a brief refresher on the company and how it has evolved over the years? Mr. Do: BioVie is a biotech company that started developing ...

"They basically make the presentation to the Dara AI as a prep for making a presentation to me," the Uber CEO recently said ...

Homes.com traffic hit 100 million average monthly visitors in 2025, as CoStar net income fell to $7 million on acquisition ...

Katharine Jarmul keynotes on common myths around privacy and security in AI and explores what the realities are, covering design patterns that help build more secure, more private AI systems.